Skip to main content

COVID-19 rebound after Paxlovid treatment likely due to insufficient exposure to the drug

A CDC study of the COVID-19 treatment drug, Paxlovid shows that instances of symptom rebound after treatment may be due to under exposure to the drug
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.